Funder
CSL Behring
Takeda Pharmaceutical Company
Reference11 articles.
1. Urticaria;Kolkhir;Nat Rev Dis Primers,2022
2. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022
3. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013
4. Urticaria and angioedema: understanding complex pathomechanisms to facilitate patient communication, disease management, and future treatment;Konstantinou;J Allergy Clin Immunol Pract,2023
5. Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity, and autoallergy;Asero;J Allergy Clin Immunol Pract,2023